Literature DB >> 26346704

A Patient Blood Management Program in Prosthetic Joint Arthroplasty Decreases Blood Use and Improves Outcomes.

Terrence J Loftus1, Larry Spratling1, Barbara A Stone2, Liang Xiao1, David J Jacofsky3.   

Abstract

The objective of this study was to determine if a Patient Blood Management (PBM) program implemented for patients undergoing THA or TKA would result in a decrease in the percentage of patients transfused PRBCs and improve outcomes. Decision support, a key driver for this program, was built into the electronic medical record. This retrospective cohort study included 12,590 patients and demonstrated a 44% decrease in the percentage of patients transfused. This was associated with a significant reduction in complications, 30 day readmissions and HLOS. A PBM program for patients undergoing prosthetic joint arthroplasty for primary and revision total hip and knee arthroplasty results in fewer transfusions and is associated with improved outcomes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  blood transfusion; hip arthroplasty; knee arthroplasty; outcomes; patient blood management; tranexamic acid

Mesh：

Year:  2015        PMID： 26346704     DOI： 10.1016/j.arth.2015.07.040

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN： 0883-5403            Impact factor:   4.757


  11 in total

1.  Impact of stem profile on the revisability and the need for osteotomy in well-fixed cemented revision total knee arthroplasty implants.

Authors:  Alexander Maslaris; Georgios Spyrou; Carsten Schoeneberg; Mustafa Citak; Georg Matziolis
Journal:  Arch Orthop Trauma Surg       Date:  2022-08-05       Impact factor: 2.928

2.  Need for preoperative anemia management clinics in Japan: initiatives at a university hospital in the USA.

Authors:  Patrick Hussey; Yoshiko Onodera; Sundara Reddy; Blain Samuelson; Sudhakar Subramani; Yatish Siddapura Ranganath; Tariq Jaradat; Satoshi Hanada
Journal:  J Anesth       Date:  2021-08-02       Impact factor: 2.078

3.  The efficacy and safety of multiple-dose oral tranexamic acid on blood loss following total hip arthroplasty: a randomized controlled trial.

Authors:  Guorui Cao; Qiang Huang; Zeyu Huang; Shaoyun Zhang; Zeyu Luo; Yiting Lei; Zongke Zhou; Fuxing Pei
Journal:  Int Orthop       Date:  2018-04-10       Impact factor: 3.075

4.  The results of a stepwise implementation of a fast-track program in total hip and knee replacement patients.

Authors:  Georgios I Drosos; Ioannis E Kougioumtzis; Stylianos Tottas; Athanasios Ververidis; Christos Chatzipapas; Grigorios Tripsianis; Konstantinos Tilkeridis
Journal:  J Orthop       Date:  2020-03-25

Review 5.  Blood Management Strategies in Total Knee Arthroplasty.

Authors:  David Liu; Michael Dan; Sara Martinez Martos; Elaine Beller
Journal:  Knee Surg Relat Res       Date:  2016-08-25

Review 6.  Perioperative blood management strategies for patients undergoing total knee replacement: Where do we stand now?

Authors:  Tzatzairis Themistoklis; Vogiatzaki Theodosia; Kazakos Konstantinos; Drosos I Georgios
Journal:  World J Orthop       Date:  2017-06-18

Review 7.  Management of Blood Loss in Hip Arthroplasty: Korean Hip Society Current Consensus.

Authors:  Joo-Hyoun Song; Jang Won Park; Young-Kyun Lee; In-Sung Kim; Jae-Hwi Nho; Kyung-Jae Lee; Kwan Kyu Park; Yeesuk Kim; Jai Hyung Park; Seung Beom Han
Journal:  Hip Pelvis       Date:  2017-06-02

8.  The combined administration of systemic and topical tranexamic acid for total hip arthroplasty: Is it better than systemic?

Authors:  Deniz Gulabi; Yucel Yuce; Kutlu Hakan Erkal; Necdet Saglam; Savas Camur
Journal:  Acta Orthop Traumatol Turc       Date:  2019-04-04       Impact factor: 1.511

9.  The efficiency and safety of oral tranexamic acid in total hip arthroplasty: A meta-analysis.

Authors:  Yipeng Xu; Shaoting Sun; Qing Feng; Guanfeng Zhang; Bin Dong; Xiaoyan Wang; Ming Guo
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

10.  Preoperative Correction of Low Hemoglobin Levels Can Reduce 1-Year All-Cause Mortality in Osteoporotic Hip Fracture Patients: A Retrospective Observational Study.

Authors:  Worapaka Manosroi; Pichitchai Atthakomol; Natthanaphop Isaradech; Phichayut Phinyo; Tanawat Vaseenon
Journal:  Clin Interv Aging       Date:  2022-02-17       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.